The FDA announced on November 17, 2022, that Ortho-Clinical Diagnostics, Inc. is recalling VITROS Immunodiagnostic Products Intact PTH Reagent Pack- IVD due to lower than expected patient and Quality Control results. The agency said the reagent packs may produce negatively biased intact parathyroid hormone readings.
How to tell if you have it
- Brand: Ortho-Clinical
- Product: VITROS Immunodiagnostic Products Intact PTH Reagent Pack- IVD
- Catalog Number: 6802892
- UDI-DI: 6802892 (10758750006267)
- Lot Numbers/Exp Date: 1610 24-Apr-2023; 1621 24-Apr-2023; 1630 08-May-2023; 1640 08-May-2023; 1645 08-May-2023; 1650 29-May-2023; 1670 06-Jun-2023
- Quantity: 4,158 units
The hazard
The recall addresses lower than expected intact parathyroid hormone (iPTH) patient and Quality Control results. The FDA said the issue involves negatively biased iPTH results, specifically an average -12% shift in patient sample results.
Context
GovInfoNow's records show Ortho-Clinical Diagnostics, Inc. has 53 other recalls on record since 2017-07-10. Other recent recalls of similar products include Ortho-Clinical VITROS LAC Slides Recall (2025-07-29), Ortho-Clinical VITROS Ca Slides Recall (2025-07-09), and Ortho-Clinical VITROS OP Reagent Gen 15 May Cause Inaccurate Test Results (2025-06-12). Other recent recalls of similar products include Siemens Dimension Tacrolimus Flex Reagent Cartridge Recall (2026-05-07), Tosoh ST AIA-Pack Testosterone Recall (2026-06-12), and Vivoo pH Test Recall (2025-11-22).